Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
WHR enters its October 26 earnings date with a fresh analyst cut landing this morning, short interest grinding higher, and a stock that has lost nearly a quarter of its value in a single month.
The most immediate development is from RBC Capital. Mike Dahl slashed his price target from $32 to $22 today, maintaining an Underperform rating. That $22 target now sits well below the current price of $30.15, making it the most bearish published target in the visible dataset. It is worth noting the context: B of A Securities already holds an Underperform with a $31 target, set on September 11, and Wells Fargo initiated at Equal-Weight with a $39 target on August 24 before cutting to $39. The direction of travel across the Street is uniformly lower. No firm has upgraded, initiated with a positive rating, or raised a target in recent months. The mean target of roughly $50 reflects older, pre-deterioration estimates and should be treated with caution given the pace of cuts since July.
Short interest has continued building since the September 30 note, rising to 28.7% of free float from 27.6%, up another 3.4% on the week and 11.8% over the past month. FINRA's fortnightly confirms 15.5 million shares short with 5.05 days to cover. The short score held at 74.3, ranking in the bottom 3rd percentile of the universe. What has changed this week is availability: it tightened to 83% of short interest from roughly 102% a week ago, a meaningful move lower. The 52-week low was 29.7%, so the borrow market is not yet in squeeze territory, and cost to borrow remains low at 0.73%. But the tightening direction is worth noting. Shorts are adding, and the pool of shares available to lend is shrinking relative to what is already borrowed.
Options positioning has shifted away from the defensive posture that characterised September. The put/call ratio has dropped to 0.76, more than one standard deviation below its 20-day average of 0.87. Through September, the PCR ran above 1.0, meaning puts were outweighing calls. That has reversed sharply. Whether this reflects covering of downside hedges, new call buying into a potential bounce, or simply lower activity on the put side ahead of earnings is not clear from the ratio alone. The 52-week PCR range runs from 0.64 to 1.35, so the current reading is toward the lower, more bullish end.
The fundamental case on both sides is stark. Bears point to Q1 2026 adjusted EBITDA falling 52% year over year to $142 million, adjusted EPS missing sharply at negative $0.56, net debt leverage above 4x, and North American pricing under sustained pressure from competition and soft housing activity. Bulls point to the valuation: price-to-book is now 0.49, the EV/EBITDA multiple has compressed by about 0.10 turns over 30 days to 8.2x, and the EPS surprise factor score ranks at the 99th percentile of the universe, meaning the company has a strong recent track record of beating lowered estimates. The 30-day EPS momentum score of 85 suggests near-term estimate revisions have been skewing positive, even as the 90-day equivalent sits at just 13. Appaloosa LP, which holds a Schedule 13D activist stake, has trimmed from 7.0% to 4.9% as last disclosed in March, and may no longer be above the 5% threshold required to file again.
Earnings history adds one more piece of colour. The last three prints produced one-day moves of 5.4%, 19.0%, and 15.3% respectively, all to the upside. The five-day moves after those prints were 5.1%, 12.5%, and 11.2%. WHR has form for large post-earnings rallies off deeply depressed prices and beaten-down expectations. With 19 days to the October 26 print, the question is whether that pattern is what the options market is beginning to position for, or whether the easing put/call ratio simply reflects fading conviction among bears who hedged through September.
What to watch: whether availability continues to tighten toward the levels seen earlier in the year, whether any further analyst target cuts push below RBC's new $22 floor, and how the PCR evolves as October 26 draws closer.
See the live data behind this article on ORTEX.
Open WHR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
